Catalyst
Slingshot members are tracking this event:
European Commission Designates Zogenix' (ZGNX) ZX008 an Orphan Medicinal Product for Lennox-Gastaut Syndrome
- Source Link:
- http://seekingalpha.com/filings/pdf/11895557.pdf
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ZGNX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Commission, Zx008, Orphan Medicinal Product, Lennox-gastaut Syndrome
